Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients

Figure 1 Sustained virological response. A: Influence of rapid virological response on sustained virological response. Patients with rapid virological response (RVR) vs patients without RVR, ^bP < 0.001; B: Influence of response to previous treatment on sustained virological response. Prior relapsers vs prior null-responders, ^aP < 0.05. Sustained virological response was analyzed 24 wk after treatment withdrawal for 122 patients (overall numbers of patients: 88 in the telaprevir group, 34 in the boceprevir group).

Figure 2 Diagnostic value of liver stiffness measurement to predict sustained virological response. The area under the receiver operating characteristic curve was 0.64 (0.52-0.76).